Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Entera Bio (ENTX) Return on Capital Employed (2018 - 2025)

Entera Bio has reported Return on Capital Employed over the past 8 years, most recently at 79.44% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 5027.0% year-over-year to 79.44%, compared with a TTM value of 79.44% through Dec 2025, up 5027.0%, and an annual FY2025 reading of 109.92%, down 797.0% over the prior year.
  • Return on Capital Employed came in at 79.44% for Q4 2025, down from 63.8% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 50.09% in Q4 2021 to a low of 467.49% in Q1 2021.
  • Median Return on Capital Employed over the past 5 years was 97.48% (2023), compared with a mean of 110.91%.
  • The sharpest move saw Return on Capital Employed crashed -57004bps in 2021, then skyrocketed 40463bps in 2022.
  • Over 5 years, Return on Capital Employed stood at 50.09% in 2021, then tumbled by -100bps to 100.19% in 2022, then increased by 2bps to 97.98% in 2023, then plummeted by -32bps to 129.71% in 2024, then skyrocketed by 39bps to 79.44% in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Return on Capital Employed are 79.44% (Q4 2025), 63.8% (Q3 2025), and 56.36% (Q2 2025).